This article focuses on several promising candidate biomarkers that may soon make their transition to the realm of clinical management of bladder cancer. Presented are superficial and muscle-invasive urothelial carcinoma of the bladder and the genetic tests currently available in testing for diagnosis and prognosis of these diseases.
- Molecular bladder
- Urothelial carcinoma
ASJC Scopus subject areas
- Pathology and Forensic Medicine